Workflow
Custom Industrial Enzymes
icon
Search documents
Codexis (CDXS) Expected to Beat Earnings Estimates: Should You Buy?
ZACKSยท 2025-04-24 15:09
Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Codexis, with a focus on how actual results compare to estimates impacting stock price [1][2] Earnings Expectations - Codexis is expected to report a quarterly loss of $0.20 per share, reflecting a 25% decrease year-over-year [3] - Projected revenues are $10.62 million, down 37.8% from the same quarter last year [3] Estimate Revisions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analyst expectations [4] - The Zacks Earnings ESP model suggests that recent estimate revisions may provide insights into business conditions [5][6] Earnings Surprise Prediction - Codexis has a positive Earnings ESP of +26.23%, indicating a potential earnings beat based on recent analyst revisions [10] - The stock holds a Zacks Rank of 3, suggesting a likelihood of beating the consensus EPS estimate [11] Historical Performance - In the last reported quarter, Codexis was expected to post a loss of $0.02 per share but instead reported a loss of $0.13, resulting in a surprise of -550% [12] - Over the past four quarters, Codexis has only beaten consensus EPS estimates once [13] Conclusion - While Codexis is positioned as a potential earnings-beat candidate, other factors should also be considered when evaluating the stock ahead of its earnings release [16]